These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30868052)

  • 1. YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN.
    Guo L; Chen Y; Luo J; Zheng J; Shao G
    FEBS Open Bio; 2019 Mar; 9(3):437-445. PubMed ID: 30868052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
    Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
    Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.
    Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J
    Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling.
    Yu S; Zhang M; Huang L; Ma Z; Gong X; Liu W; Zhang J; Chen L; Yu Z; Zhao W; Liu Y
    Aging (Albany NY); 2019 Dec; 11(24):12295-12314. PubMed ID: 31848326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
    Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
    Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
    Lin C; Xu X
    Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
    Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
    Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
    Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
    Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
    Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
    Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
    Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling.
    Sun JG; Chen XW; Zhang LP; Wang J; Diehn M
    Oncotarget; 2016 Mar; 7(9):9692-706. PubMed ID: 26695440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
    Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
    PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACSL3 regulates breast cancer progression
    Tan S; Sun X; Dong H; Wang M; Yao L; Wang M; Xu L; Xu Y
    Cancer Biol Med; 2024 Jul; 21(7):606-35. PubMed ID: 38953696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.